Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090713 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
A Phase 3 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT01090713: Completed Phase 3 study, sponsored by Lindner Center of HOPE.
NCT01090713 is a Phase 3 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 50 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01090713, a Phase 3 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
Primary Outcome
frequency of binge eating episode
Interventions
- DRUG Placebo control
- DRUG lisdexamfetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
What the finished NCT01090713 record still lists
NCT01090713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT01090713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01090713 about?
NCT01090713 is a clinical study titled "Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder". The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
What is the current status of trial NCT01090713?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2010-01. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01090713?
The interventions under investigation include: Placebo control (DRUG), lisdexamfetamine (DRUG).
Who is sponsoring clinical trial NCT01090713?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01090713's enrollment target sits among peer trials
50 1844th of 2000 higher than 141 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia